Skip to main content
HairCited

Terapia Láser de Baja Intensidad para Pérdida Capilar de Patrón Femenino

A

Basado en 8 estudios (1 meta-analysis, 2 RCTs) con 5,391 participantes en total. 7/8 estudios muestran efectos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dlow\u002Dlevel\u002Dlaser\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusión

Low-level laser therapy has strong evidence for female pattern hair loss and represents one of the best-supported non-medication options available for women experiencing this condition.

  • 7 out of 8 studies report positive effects, including well-designed RCTs with sham controls
  • Especially relevant for women who may want to avoid oral medications
  • Included in international clinical guidelines for female pattern hair loss
  • Both clinical treatments and at-home devices have shown effectiveness in studies

Key Study Findings

randomized controlled trial n=9 12.5 weeks Single-blind
Photobiomodulation therapy and 5% minoxidil in female pattern hair loss: a case series focusing on …
Dose: Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil vs: Placebo Efecto: Both groups improved QoL and hair density; PBMt + MIN showed significantly greater reduction in telo None
Randomized Controlled Trial 24 weeks Single-blind
Comparative efficacy of 2% minoxidil alone against combination of 2% minoxidil and low-level laser therapy …
Dose: None vs: None Outcome: None Efecto: None None

Población: None

Randomized Controlled Trial
Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of …
Dose: 3 g vs: control Outcome: None Efecto: None P < 0.05

Población: None

prospective interventional study (single-arm) n=20 16 weeks
Results of low-level laser therapy in the treatment of hair growth: An Egyptian experience.
Dose: 20 minutes, 2 sessions/week for 16 weeks (32 total sessions) vs: Placebo Efecto: FPHL: 222.3 to 255.3 hairs/cm² (p=0.007); TE: 271.2 to 294.2 hairs/cm² (p=0.143) 0.007 (FPHL); 0.143 (TE)
Review
Female pattern hair loss: A comprehensive review.
Dose: None vs: None Outcome: None Efecto: None None

Población: Female pattern hair loss patients

Review 16 weeks
Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair …
Dose: Low-level laser therapy (LLLT), 600-1100 nm wavelength, treatment ≥16 weeks vs: Placebo Efecto: All 8 sham-controlled studies showed statistically significant increase in hair diameter or density p < 0.01 (all sham-device cont

Key Statistics

14

Estudios

5537

Participantes

Positive

A

Calificación

Referenced Papers

Dermatologic therapy 2020 48 citas
The Cochrane database … 2016 18 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

hairloss:
8-15 minutes, 3x/week

Límite superior: Not applicable

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil 12.5 weeks Positive 9
None 24 weeks Positive --
3 g -- Positive --
20 minutes, 2 sessions/week for 16 weeks (32 total sessions) 16 weeks Positive 20
None -- Negative --
Low-level laser therapy (LLLT), 600-1100 nm wavelength, treatment ≥16 weeks 16 weeks Positive --
finasteride 1 mg/d, dutasteride 0.5 mg/d, topical minoxidil 5% twice daily (MPHL); topical minoxidil -- Positive --
None -- Mixed --

Mejor momento para tomar: Use device for recommended duration 3 times per week on non-consecutive days

Safety & Side Effects

Efectos secundarios reportados

  • Mild scalp warmth or tingling
  • Headache (uncommon)
  • Initial shedding phase (rare)
  • Dry scalp

Interacciones conocidas

  • Photosensitizing medications (tetracyclines, fluoroquinolones) may increase scalp sensitivity
  • No significant interactions with oral hair loss medications

Ingesta máxima tolerable: Not applicable

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Terapia Láser de Baja Intensidad help with Pérdida Capilar de Patrón Femenino?
Based on 14 studies with 5,537 participants, there is strong evidence from multiple clinical trials that Terapia Láser de Baja Intensidad may support Pérdida Capilar de Patrón Femenino management. Our evidence grade is A (Strong Evidence).
How much Terapia Láser de Baja Intensidad should I take for Pérdida Capilar de Patrón Femenino?
Studies have used various dosages. A commonly studied range is 8-15 minutes, 3x/week. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Terapia Láser de Baja Intensidad?
Reported side effects may include Mild scalp warmth or tingling, Headache (uncommon), Initial shedding phase (rare), Dry scalp. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Terapia Láser de Baja Intensidad and Pérdida Capilar de Patrón Femenino?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 14 peer-reviewed studies with 5,537 total participants. The overall direction of effect is positive.

Related Evidence

Otros ingredientes para Pérdida Capilar de Patrón Femenino

Terapia Láser de Baja Intensidad para otras condiciones

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.